chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Showing signs of hyperthyroidism; A spontaneous report was received from a consumer concerning a 68-year-old, female patient who received Moderna's COVID-19 vaccine and developed signs of hyperthyroidism.  The patient's medical history was hypothyroidism. No relevant concomitant medications were reported.  On 06 Jan 2021, patient received their first of two planned doses of mRNA-1273 (Batch number 026L20A) injection for the prophylaxis of COVID-19 infection.  On 02 Feb 2021, within 28 days of receiving vaccine, patient had a six-month checkup that showed signs of hyperthyroidism when patient has history of hypothyroidism. The patient's healthcare professional consent was obtained. Treatment for the event was not provided.  Action taken with the event was not reported.  The outcome of the event, signs of hyperthyroidism, was considered ongoing.; Reporter's Comments: Very limited information regarding the event has been provided at this time and is insufficient for causality assessment.  However, the patient's history of hypothyroidism may confound causality assessment. Further information has been requested.
Extreme fatigue. Extreme muscle aches in both arms, both legs, back & torso. Elevated heart rate. Headache.
Information has been received from a registered nurse concerning a 14 year old female patient who was vaccinated with her second dose of GARDASIL. Subsequently the patient developed a breast infection. The infection was treated with antibiotics. Her breast became hard with a rash. She still had a lump at the site of the infection. The patient had sought medical attention in office. At the time of reporting, the patient was recovering from the adverse events. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of feeling hot in a 66-year-old male patient who received SHINGRIX for prophylaxis. On 30th June 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 30th June 2018, several hours after receiving SHINGRIX, the patient experienced feeling hot, difficulty in standing, fatigue and feeling cold. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the feeling hot, difficulty in standing, fatigue and feeling cold were recovering/resolving. It was unknown if the reporter considered the feeling hot, difficulty in standing, fatigue and feeling cold to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in right deltoid. The patient got the vaccine in the morning and began to develop side effects by that evening. He was having difficulty standing for long periods of time because of fatigue. He was taking Tylenol to treat his symptoms and was feeling better on the day of reporting.
Post vax the patient's mother noticed a splotchy, itchy rash at approximately 8:30 - 9:00PM. The patient slept well. The patient was seen by the Dr on 10/19/2001 and treated with Benadryl.
Information has been received from a healthcare worker reporting on a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions/allergies, pertinent medical history or concomitant medication. On 30-OCT-2017, the patient received an improperly stored dose of LIQUID PEDVAXHIB lot # N012120, expiration date 30-JAN-2020 or lot # N000235, expiration date 26-OCT-2019 or lot # N007749, expiration date 29-NOV-2019 for prophylaxis (dose, anatomical location and route of administration were not reported). It was reported that on an unspecified date, the vaccine was exposed to a temperature between 9 Celsius degrees and 25 Celsius degrees for 47 hours and 39 minutes. The vaccine did not undergo a previous temperature excursion. The call was placed because of a Digital Data logger report. No adverse effects were reported. This report is one of multiple reports received from the same reporter.; Sender's Comments: US-009507513-1711USA006083: US-009507513-1711USA013917: US-009507513-1711USA013918: US-009507513-1711USA013919: US-009507513-1711USA013920: US-009507513-1711USA013921: US-009507513-1711USA013913: US-009507513-1711USA013914: US-009507513-1711USA013915:
At 10pm on 5/18/2021 I started having side effects, 9 hours after vaccination. My face and ears were hot and my body was cold, I felt very fatigued. I took Tylenol before bed and woke up in the middle of the night drenched in sweat. I woke up officially at 8am and felt my face and eyes were swollen, I also had chest tightness. I looked in the mirror and it looks like I was punched in the face. My left eye (the side I was vaccinated) is significantly more swollen than my right side. Since 8am, the swelling and puffiness hasn?t gone down in my face, however, the chest tightness went away. I took Benadryl. It is now almost 4pm on 5/19/2021 and I still have the same amount of swelling and puffiness in my face. It?s extreme enough that I can?t go out in public like this or else someone will think I got beat up. There isn?t any bruising, rather, under each eye there are very prominent dark circles with almost a reddish tint. It seems like this possibly could be an allergic reaction but after reading online it seems like allergic reactions would have happened right after vaccine. I noticed this side effect 19 hours after vaccination when I woke up on 5/19/2021. If it?s not better when I wake up tomorrow on 05/20/2021 I will goto urgent care.
Altered taste; Headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EW0179, expiration date: 31Aug2021), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. Medical history included high cholesterol. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. On an unknown date, the patient experienced altered taste and headache after a week and still going on. Patient did a COVID-19 test on an unspecified date and result was negative. It was also reported that since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken for the events. The clinical outcome of the events altered taste and headache was not recovered.  No follow-up attempts are needed. No further information is expected.
MODERNA COVID-19 VACCINE EUA. Started feeling achy and feverish night of vaccine.  No temp.  Fell asleep for a while and when I woke up had pain in my right hip going down my leg like sciatica!  Following day, Thursday,  the pain was worse and had trouble standing on leg.  Rested all day.  Not really pain anywhere else, just right hip and down leg.  Friday morning felt better but started again in the afternoon and evening.  Saturday went to Urgent Care as the pain was very bad, could barely stand on my leg again.  Was given Flexeril and Naproxyn which is not touching it!  Using heat and ice.  Right now nothing is working.  Hard time standing on leg.
Body aches; congestion; Had a fever; didn't feel  good; Felt  tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (didn't feel  good), PAIN (Body aches), NASAL CONGESTION (congestion), FATIGUE (Felt  tired) and PYREXIA (Had a fever) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 31-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2021, the patient experienced FEELING ABNORMAL (didn't feel  good) and FATIGUE (Felt  tired). On 01-Jan-2022, the patient experienced PAIN (Body aches), NASAL CONGESTION (congestion) and PYREXIA (Had a fever). At the time of the report, FEELING ABNORMAL (didn't feel  good) and FATIGUE (Felt  tired) outcome was unknown and PAIN (Body aches), NASAL CONGESTION (congestion) and PYREXIA (Had a fever) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jan-2022, COVID-19: positive (Positive) Tested positive with rapid test.         Patient took concomitant products as blood pressure medicine and allergy medicine. Treatment information was not provided.
Information has been received from a Practice Administrator concerning a 24 year old female Registered Nurse patient, who on 01-MAR-2011 was preparing to administer a dose of MMR II (lot # unspecified) accidentally splashed some of it in her eye from the vial. Subsequently, the patient experienced burning in her eye. The eye was immediately flushed with water, and the physician on staff, examined the patient's eye. At the time of the report patient's outcome was not reported. Additional information has been requested.
Information has been received from a certified nurse practitioner concerning a 22 year old female patient who on 16-MAR-2010, was vaccinated with the first dose of GARDASIL (Lot#662299/1099Y). The certified nurse practitioner reported that "a while after she received the shot" the patient started having itchy head and started getting hives on her face. The patient sought unspecified medical attention. The nurse told the patient to take BENADRYL and the next day the patient was feeling better and the itchiness and swelling went down a lot. Follow-up information has been received from a nurse practitioner, who reported that the patient developed a localized urticaria on her face and neck within 30 minutes of administration of her first dose of GARDASIL on 16-MAR-2010. The patient was treated with BENADRYL. On 18-MAR-2010, the patient was seen in an urgent care facility and was prescribed prednisone and ranitidine. The hives initially resolved but the patient continued to experience episodes of intermittent hives. On 14-APR-2010, the patient developed widespread urticaria. She was seen again at the urgent care facility on 15-APR-2010, and was prescribed SOLUMEDROL. On 15-APR-2010, the nurse practitioner examined the patient in the office and had added ranitidine therapy. Upon internal review, the administration of SOLUMEDROL for widespread urticaria was considered to be an other important medical event. No further information is available.
She received a Moderna booster at age 16 instead of Pfizer booster.  Her mom, said she chose Moderna on purpose even though only Pfizer was approved since the booster was half of the normal dose since the daughter plays high school basketball and she wanted her daughter to be protected along with the other players and her grandmother. Mother said her and daughter's bodies react the same ways to medications and daughter didn't have any issues with the booster in November. She said she felt like she made the right choice in getting the Moderna even though it is technically only approved for 18 years and older and did not mention this to the technician who gave her the vaccine. She did mention that the technician asked her which vaccine she was getting and they told her Moderna. She also chose to get Moderna on our scheduling link, but we did not catch that she was 16 years old at the time on vaccination based on the DOB alone.
First night after 2nd dose was the common chills, fever, fatigue.  I have been fatigued ever since, almost 4 weeks later. In the past 2 weeks, so 2 weeks after 2nd dose I have had abdominal pain possibly in liver, constant hunger pains and constant nausea and continuing fatigue.
headache; sore throat; very sore arm the following day.; This is a spontaneous report from a non-contactable consumer or other non hcp.   A 33-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on Feb2021 (Batch/Lot Number: EL3247) as UNKNOWN, SINGLE for covid-19 immunisation  .  Medical history included psoriatic arthropathy from an unknown date and unknown if ongoing.     The patient's concomitant medications were not reported.  The patient experienced headache (headache) (non-serious) on 25Feb2021 with outcome of recovered , sore throat (oropharyngeal pain) (non-serious) on 25Feb2021 with outcome of recovered , very sore arm the following day. (pain in extremity) (non-serious) on 25Feb2021 with outcome of recovered.  The action taken in response to the event(s) for bnt162b2 was not applicable.
MODERATE AND CONSISTENT ABDOMINAL PAIN; BODY ACHES; SOARED; FEVER; REALLY TIRED; This spontaneous report received from a patient concerned a 19 year old male. The patient's weight was 170 pounds, and height was 70 inches. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 31-MAR-2021, the subject experienced body aches. On 31-MAR-2021, the subject experienced soared. On 31-MAR-2021, the subject experienced fever. On 31-MAR-2021, the subject experienced really tired. On 13-APR-2021, the subject experienced moderate and consistent abdominal pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, soared, fever, and really tired on 01-APR-2021, and had not recovered from moderate and consistent abdominal pain. This report was non-serious.
BLOOD CLOTS; SUSPECTED IMMUNOLOGICAL VACCINE FAILURE; WHOLE BODY HURTS AND CANNOT FIND RELIEF; TIRED; WEAK ALL THE TIME; This spontaneous report received from a patient via a company representative via social media concerned a patient of unspecified age, sex, race and ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: autoimmune disease (kept under control with exercise and Ibuprofen), and other pre-existing medical conditions included: At the time of report patient was healthy except autoimmune disease. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, 01 total administered, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. Concomitant medications included ibuprofen for autoimmune disease. On an unspecified date since the vaccine, the patient developed blood clots and started blood thinners, patient whole body hurts and cannot find relief, tired, and weak all the time. The patient stated that vaccine destroyed immune system and on an unspecified date, the patient did not had antibodies like science claimed which resulted into suspected immunological vaccine failure. Reporter stated that, "Took one covid vax. I already had an autoimmune disease. Since the vax I have had blood clots so I am on blood thinner, my whole body hurts and cannot find relief. I'm tired and feel weak all the time. I was healthy except for my autoimmune disease, which I kept under control with exercise and Ibuprofen which now you cannot take with my blood thinner. Thank God I only had one. Basically destroyed my immune system. Did not give me antibodies like science claimed" The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clots, whole body hurts and cannot find relief, tired, and weak all the time, and the outcome of suspected immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with Product quality complaint: 90000262878.; Sender's Comments: V0: 20221225837- blood clots.  The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable. 20221225837-suspected immunological vaccine failure . The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event. Specifically: SPECIAL SITUATIONS. Therefore, this event is considered inconsistent with vaccine administration.
Swollen lymph node on left side (same as injection side) Dizziness  Fatigue
Itching was first thing.  At site, swollen and red.  I began to take Benadryl 2 times per day for 3 days.  Normal after that time.
This spontaneous report as received from an unspecified reporter refers to a patient of unknown age and gender. On 05-FEB-2015 the patient was vaccinated with M-M-R II (route, dose, frequency and lot # not reported) which underwent an excursion (on an unspecified date). This is one of several reports from the same source. Additional information has been requested.
light headed immediately after injection, feeling "not right" one hour later, felt top of mouth tingling  and malaise, woke up in morning with grossly swollen upper lip. No airway restriction noted. Given 50 mg oral of benedryl. Contacted physician. Will continue to monitor at home and will call doctor again if reaction persists.
patient reports pain and pressure in ears lasting about 4 weeks and currently resolved, and low pitch constant tinnitus that was severe and very distressing for the first week or so to the point that he considered harming himself.  The tinnitus persists but is less distressing.  He was treated at Urgent Care with a steroid dose pack, a course of prednisone 40 mg/day x 5 days, 10 days of augmentin 875 mg po bid and a week of cortisporin ear drops.  None of the treatment helped the tinnitus.  He refused an audiogram to evaluate the tinnitus and denies preexisting tinnitus.
Patient admitted to hospital 8/10/21.  COVID test positive 8/12/21. Deceased 9/13/21
approx 2wk p/vax pt devel sore throat, rt ear pain, body aches & h/a;
breastfeeding for baby; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (breastfeeding for baby) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced EXPOSURE VIA BREAST MILK (breastfeeding for baby). At the time of the report, EXPOSURE VIA BREAST MILK (breastfeeding for baby) had resolved.            Reporter did not allow further contact
hives covering entire body including soft palate, headache, body aches, stiff joints, fatigue  Depo medrol injection, Prednisone 20 mg/day X 4 days; Zyrtec X 12 days, Benadryl X 12 days
09/30/21: NASAL CONGESTION, RUNNY NOSE, POSTNASAL DRAINAGE
To emergency room on 10 2, Pneumonia, afib, spent 1 night in ICU and 1 night in hospital.   Now week, lung capacity down
Slight swelling on left arm under the spot given shot, slight redness and itchiness to the next day, some chills and goosebumps.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 15-MAR-2013, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) for its intended purpose; to prevent shingles. As a direct result of the vaccine, the patient suffered from a shingles outbreak, in addition to chronic pain, rash and lesions to various parts of his body. The patient did not have a shingles outbreak until 25-JAN-2017. As a direct result of the vaccine, the patient, suffered mental and emotional distress due to resulting physical limitations and seriousness of his condition. Additional information has been requested.
Shingles on forearm; rash on other side of forearm and upper arm area; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6205) via an unspecified route of administration on 16Apr2021 at 12:00 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history included that the patient was allergic to sunblock. Concomitant medications included Allopurinol (MANUFACTURER UNKNOWN) from an unknown date and unknown if ongoing for an unknown indication. The patient also received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 25Mar2021 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21May2021 the patient experienced shingles on forearm and rash on other side of forearm and upper arm area. Therapeutic measures were not taken as a result of the events shingles on forearm and rash on other side of forearm and upper arm area. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events shingles on forearm and rash on other side of forearm and upper arm area was not resolved.   No follow-up attempts are needed. No further information is expected.
16 year old received Pfizer dose #1 (Lot # EW0158) @ 1155 am. While in the recovery area @1156 began feeling dizzy and faint. Was lowered to the floor and placed in Trendelenburg position.  First set of vital done at 1158am. 138/62, 18, 92, @ 96% O2 sat.  Mom stated that this is not a new event, has a history of syncope with injections.  Second set of vitals @ 1158, 118/60, 84, 99% O2 sat. Returned to chair. Had a second episode,  and was once again lowered to the floor, and positioned with head between knees and did deep breathing exercises.  Next set of vitals at 1209 am, 118/62, 77,  18, 98% O2 sats.  Returned to chair when stating he felt better. Discharged from Recovery with Mother to home at 1233 am with final set of vitals of 110/70, 64, 18.
Left ear: Ringing in ear, hearing loss, tinnitus Steroid shot injection in eardrum Not resolved
Redness, swelling, and hot at site of inj, swelling and redness covered about 4 inch in area with hard lump, diarrhea, low grade fever. Developed sinusitis, bronchitis, following viral onset.
Significant pain through entire muscle of injection site. Gradual onset to highest pain level over 6 hours. Range of motion decreased. By day 3, it was gone. I took some ibuprofen to helpthe injection site. Day 9 started feeling unusual ?quarter sized? specific pain sites (left upper thigh, right upper thigh, left wrist). One spot at a time until today day 11 and each spot throbs in sync. Not sure if it?s related but thought since it?s a strange and unusual occurrence it may have something to do with the vaccine.
Patient reported having severe migraine headache, swelling of a large area of arm, hip pain.
-pain in right side of entire body,  -entire face rash-  rash on face- could be from epiduo forte which is used 2x/week for the last 2 months ?  -chills